Review Version 1 This version is not peer-reviewed
The Immune System View of the Coronavirus SARS-CoV-2
Version 1 : Received: 2 December 2020 / Approved: 3 December 2020 / Online: 3 December 2020 (09:20:35 CET)
How to cite: Celardo, I.; Pace, L.; Cifaldi, L.; Gaudio, C.; Barnaba, V. The Immune System View of the Coronavirus SARS-CoV-2. Preprints 2020, 2020120075 Celardo, I.; Pace, L.; Cifaldi, L.; Gaudio, C.; Barnaba, V. The Immune System View of the Coronavirus SARS-CoV-2. Preprints 2020, 2020120075
Knowing the “point of view” of the immune system is essential to understand the characteristic of a pandemic, such as that generated by the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)-2, responsible for the Coronavirus Disease (COVID)-19. In this review, we will discuss the general host/pathogen interactions dictating protective immune response or immunopathology, addressing the role of immunity or immunopathology in influencing the clinical infection outcome, and debate the potential immunoprophylactic and immunotherapy strategies required to fight the virus infection.
COVID-19; SARS-CoV-2; vaccine; coronavirus; monoclonal antibodies
LIFE SCIENCES, Biochemistry
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.Leave a public comment
Send a private comment to the author(s)